Cassandra Pardini, PharmD

Most Recent Articles by Cassandra Pardini, PharmD

Combo Tofacitinib Plus Methotrexate vs Adalimumab Plus Methorexate Tx

By Jun 30, 2017

Fleischmann, R et al. "Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial." DOI:

Single-Tablet Elvitegravir, Cobicistat, Emtricitabine, & Tenofovir Alafenamide in Virologic Suppressed Children with HIV

By Jun 29, 2017

Natukunda, E et al. "Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial." DOI:

Rituximab Plus Autologous Stem-Cell Transplant in Diffuse Large B-Cell Lymphoma

By Jun 28, 2017

Chiappella, A et al. "Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study." DOI:

Inactivated Influenza Vaccine Delivered by Microneedle Patch

By Jun 27, 2017

Rouphael, NG et al. "The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial." DOI:

Empagliflozin Effects on the Urinary Albumin-to-Creatinine Ratio in T2D, Heart Disease Patients

By Jun 27, 2017

Cherney, DZ et al. "Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial." DOI:

More Articles by Cassandra Pardini, PharmD